SW
SMART Wealth LLC
13F filer · CIK 0002044723Reported Aug 6, 2026
13F portfolio value$464MU.S. long equity reported on 13F
Positions98Not reported new · Not reported closed
Net flow last quarterNot reportedBuys minus sells
Top 10 positions weight14.9%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 6, 202698 positions | |||||
| $15.3M | 3.29% | 0.00% | +0.3% | Q2 2023 | |
| $9.78M | 2.11% | Not reported | +942.4% | Q4 2022 | |
| $8.8M | 1.90% | 6.03% | +114.2% | Q3 2025 | |
| $5.85M | 1.26% | Not reported | Not reported | Q3 2024 | |
| OBONEZOne Bio, Corp. | $5.38M | 1.16% | Not reported | +59.0% | Q1 2025 |
| $5.24M | 1.13% | 0.00% | +20.7% | Q1 2026 | |
| $5.23M | 1.13% | 0.00% | -32.1% | Q2 2025 | |
| $5.13M | 1.11% | Not reported | -16.4% | Q4 2022 | |
| $4.33M | 0.93% | 0.00% | +9.1% | Q4 2022 | |
| $3.99M | 0.86% | 0.00% | -15.8% | Q4 2022 | |
| $3.71M | 0.80% | 0.01% | Not reported | Q3 2025 | |
| $3.07M | 0.66% | Not reported | -9.0% | Q1 2024 | |
| $2.97M | 0.64% | 0.00% | +362.9% | Q1 2026 | |
| $2.82M | 0.61% | 0.00% | New | Q2 2026 | |
| $2.8M | 0.60% | 0.00% | +74.0% | Q4 2025 | |
| $2.56M | 0.55% | 0.02% | -2.8% | Q2 2023 | |
| $2.47M | 0.53% | Not reported | +17.7% | Q4 2022 | |
| $2.37M | 0.51% | 0.00% | +14.2% | Q2 2023 | |
| $2.3M | 0.50% | 0.00% | +234.9% | Q2 2024 | |
| $2.28M | 0.49% | 0.06% | -6.4% | Q4 2022 | |
| $2.15M | 0.46% | 0.02% | New | Q2 2026 | |
| $2.11M | 0.46% | 0.00% | -26.3% | Q3 2025 | |
| $2.06M | 0.44% | Not reported | New | Q2 2026 | |
| $1.97M | 0.42% | Not reported | -67.1% | Q4 2023 | |
| $1.93M | 0.42% | 0.02% | -33.7% | Q1 2025 | |
| $1.77M | 0.38% | 0.00% | +15.9% | Q4 2022 | |
| $1.66M | 0.36% | 0.49% | +174.3% | Q4 2025 | |
| $1.65M | 0.36% | 0.01% | +191.1% | Q1 2026 | |
| $1.62M | 0.35% | Not reported | +22.2% | Q2 2024 | |
| $1.56M | 0.34% | 0.02% | -18.4% | Q1 2024 | |
| $1.5M | 0.32% | Not reported | New | Q2 2026 | |
| $1.5M | 0.32% | Not reported | Not reported | Q4 2022 | |
| $1.4M | 0.30% | 0.00% | +206.5% | Q1 2026 | |
| $1.34M | 0.29% | 0.15% | -7.4% | Q4 2025 | |
| $1.24M | 0.27% | 0.00% | -18.6% | Q4 2022 | |
| $1.14M | 0.25% | 0.15% | -1.8% | Q4 2024 | |
| $1.12M | 0.24% | 0.00% | -4.4% | Q4 2022 | |
| $1.1M | 0.24% | 0.00% | -65.7% | Q3 2024 | |
| $1.08M | 0.23% | 0.00% | +347.9% | Q1 2025 | |
| $1.04M | 0.22% | 0.00% | New | Q2 2026 | |
| $1.03M | 0.22% | 0.00% | -12.5% | Q3 2025 | |
| $1.03M | 0.22% | 0.00% | +7.9% | Q3 2024 | |
| $1.03M | 0.22% | 0.00% | Not reported | Q1 2025 | |
| $1.02M | 0.22% | 0.00% | -23.6% | Q3 2024 | |
| $895K | 0.19% | 0.00% | -7.2% | Q4 2025 | |
| $811K | 0.17% | 0.00% | New | Q2 2026 | |
| $787K | 0.17% | 0.00% | Not reported | Q1 2024 | |
| $756K | 0.16% | 0.01% | New | Q2 2026 | |
| $750K | 0.16% | 0.00% | -6.7% | Q4 2023 | |
| $725K | 0.16% | Not reported | -17.4% | Q1 2026 | |
| Q1 2026Reported Apr 23, 202697 positions | |||||
| $13.3M | 3.88% | 0.00% | +15.9% | Q2 2023 | |
| $5.88M | 1.72% | Not reported | +5.2% | Q4 2022 | |
| $4.69M | 1.37% | Not reported | -22.7% | Q4 2023 | |
| $4.63M | 1.36% | 0.00% | +0.5% | Q4 2022 | |
| $4.16M | 1.22% | 0.00% | +20.0% | Q4 2022 | |
| $3.41M | 1.00% | 0.02% | -37.5% | Q2 2023 | |
| $3.35M | 0.98% | Not reported | -7.0% | Q1 2024 | |
| $3.1M | 0.91% | 0.06% | -36.5% | Q4 2022 | |
| OBONEZOne Bio, Corp. | $3.07M | 0.90% | Not reported | -6.0% | Q1 2025 |
| $2.95M | 0.86% | 2.81% | -29.3% | Q3 2025 | |
| $2.47M | 0.72% | 0.00% | +229.3% | Q3 2024 | |
| $2.32M | 0.68% | 0.00% | Not reported | Q2 2025 | |
| $2.25M | 0.66% | 0.00% | -41.6% | Q2 2025 | |
| $2.21M | 0.65% | 0.02% | +2.5% | Q1 2024 | |
| $2.15M | 0.63% | 0.00% | +125.4% | Q3 2025 | |
| $2.02M | 0.59% | 0.03% | -5.5% | Q1 2025 | |
| $1.92M | 0.56% | 0.00% | +89.1% | Q4 2025 | |
| $1.9M | 0.56% | Not reported | +8.5% | Q4 2022 | |
| $1.84M | 0.54% | 0.00% | New | Q1 2026 | |
| $1.67M | 0.49% | 0.00% | -15.1% | Q2 2023 | |
| $1.54M | 0.45% | 0.13% | +27.2% | Q4 2024 | |
| $1.51M | 0.44% | 0.00% | +1.3% | Q4 2022 | |
| $1.44M | 0.42% | Not reported | Not reported | Q4 2022 | |
| $1.34M | 0.39% | 0.00% | -29.1% | Q4 2022 | |
| $1.32M | 0.39% | 0.00% | +55.7% | Q4 2025 | |
| $1.2M | 0.35% | 0.17% | +46.8% | Q4 2025 | |
| $1.18M | 0.35% | 0.00% | -10.6% | Q3 2024 | |
| $1.08M | 0.32% | Not reported | -26.1% | Q2 2024 | |
| $1.01M | 0.30% | 0.00% | -44.7% | Q2 2025 | |
| $1.01M | 0.30% | 0.00% | -3.4% | Q4 2022 | |
| $918K | 0.27% | 0.00% | +176.8% | Q3 2024 | |
| $889K | 0.26% | Not reported | +278.1% | Q3 2025 | |
| $823K | 0.24% | 0.00% | -21.1% | Q4 2022 | |
| $817K | 0.24% | Not reported | -7.9% | Q4 2022 | |
| $800K | 0.23% | Not reported | New | Q1 2026 | |
| $782K | 0.23% | 0.00% | -66.6% | Q3 2024 | |
| $749K | 0.22% | 0.00% | -73.4% | Q1 2025 | |
| $722K | 0.21% | 0.00% | -5.0% | Q4 2023 | |
| $647K | 0.19% | Not reported | New | Q1 2026 | |
| $643K | 0.19% | 0.00% | +4.8% | Q4 2022 | |
| $628K | 0.18% | 0.00% | New | Q1 2026 | |
| $582K | 0.17% | 0.00% | +14.7% | Q3 2025 | |
| $543K | 0.16% | 0.00% | -10.7% | Q2 2024 | |
| $524K | 0.15% | 0.00% | Not reported | Q1 2024 | |
| $517K | 0.15% | 0.00% | New | Q1 2026 | |
| $511K | 0.15% | 0.00% | +4.9% | Q4 2022 | |
| $509K | 0.15% | 0.18% | +154.0% | Q4 2025 | |
| $497K | 0.15% | 0.00% | New | Q1 2026 | |
| $490K | 0.14% | Not reported | +0.4% | Q4 2025 | |
| $476K | 0.14% | 0.00% | New | Q1 2026 | |
| Q4 2025Reported Jan 26, 202696 positions | |||||
| $12.2M | 3.73% | 0.00% | +0.7% | Q2 2023 | |
| $6.46M | 1.97% | Not reported | +13.3% | Q4 2023 | |
| $5.86M | 1.79% | Not reported | -2.4% | Q4 2022 | |
| $5.29M | 1.61% | 0.04% | -10.5% | Q2 2023 | |
| $4.62M | 1.41% | 0.09% | -13.6% | Q4 2022 | |
| $4.45M | 1.36% | 3.98% | +29.7% | Q3 2025 | |
| $4.24M | 1.29% | 0.00% | +0.6% | Q4 2022 | |
| $3.71M | 1.13% | 0.00% | +5.6% | Q4 2022 | |
| $3.42M | 1.04% | 0.00% | +15.3% | Q1 2025 | |
| OBONEZOne Bio, Corp. | $3.39M | 1.03% | Not reported | +17.6% | Q1 2025 |
| $3.3M | 1.01% | Not reported | +0.3% | Q1 2024 | |
| $3.26M | 0.99% | 0.00% | +640.4% | Q2 2025 | |
| $2.79M | 0.85% | 0.02% | +29.0% | Q1 2024 | |
| $2.62M | 0.80% | 0.00% | Not reported | Q3 2024 | |
| $2.52M | 0.77% | 0.00% | Not reported | Q4 2024 | |
| $2.15M | 0.66% | 0.03% | -21.1% | Q1 2025 | |
| $2.14M | 0.65% | 0.00% | Not reported | Q2 2023 | |
| $2.12M | 0.65% | 0.01% | +623.7% | Q3 2025 | |
| $2.09M | 0.64% | 0.00% | +24.2% | Q4 2022 | |
| $2.08M | 0.64% | 0.00% | +28.3% | Q2 2024 | |
| $1.96M | 0.60% | 0.00% | +26.9% | Q2 2025 | |
| $1.95M | 0.59% | 0.00% | -17.8% | Q4 2022 | |
| $1.81M | 0.55% | 0.00% | New | Q4 2025 | |
| $1.72M | 0.52% | 0.08% | +26.6% | Q4 2024 | |
| $1.72M | 0.52% | Not reported | -6.8% | Q4 2022 | |
| $1.6M | 0.49% | 0.00% | +71.7% | Q3 2024 | |
| $1.6M | 0.49% | Not reported | Not reported | Q2 2024 | |
| $1.28M | 0.39% | 0.00% | -1.4% | Q4 2022 | |
| $1.11M | 0.34% | 0.00% | -8.2% | Q4 2022 | |
| $1.11M | 0.34% | 0.11% | New | Q4 2025 | |
| $930K | 0.28% | Not reported | -13.8% | Q4 2022 | |
| $876K | 0.27% | 0.00% | Not reported | Q3 2024 | |
| $832K | 0.25% | 0.00% | -7.1% | Q4 2023 | |
| $825K | 0.25% | 0.00% | +8.7% | Q3 2025 | |
| $738K | 0.22% | 0.00% | -38.3% | Q1 2025 | |
| $653K | 0.20% | 0.00% | New | Q4 2025 | |
| $616K | 0.19% | 0.00% | +81.4% | Q3 2025 | |
| $588K | 0.18% | 0.00% | Not reported | Q1 2025 | |
| $586K | 0.18% | 0.00% | +9.6% | Q4 2022 | |
| $577K | 0.18% | 0.00% | -34.1% | Q2 2025 | |
| $550K | 0.17% | 0.00% | +63.3% | Q4 2022 | |
| $545K | 0.17% | 0.00% | -4.2% | Q2 2024 | |
| $494K | 0.15% | 0.00% | +48.5% | Q3 2025 | |
| $484K | 0.15% | Not reported | New | Q4 2025 | |
| $443K | 0.14% | 0.00% | New | Q4 2025 | |
| $436K | 0.13% | 0.00% | -7.1% | Q2 2025 | |
| $430K | 0.13% | Not reported | -20.8% | Q1 2024 | |
| $424K | 0.13% | 0.00% | Not reported | Q1 2024 | |
| $420K | 0.13% | Not reported | +5.2% | Q4 2024 | |
| $413K | 0.13% | 0.00% | +3.6% | Q4 2022 | |
| Q3 2025Reported Nov 7, 202570 positions | |||||
| $12.2M | 4.59% | 0.00% | +7.6% | Q2 2023 | |
| $6.01M | 2.27% | Not reported | -22.8% | Q4 2022 | |
| $5.57M | 2.10% | Not reported | +49.7% | Q4 2023 | |
| $3.92M | 1.48% | 0.05% | -2.3% | Q2 2023 | |
| $3.78M | 1.43% | 0.00% | +0.5% | Q4 2022 | |
| $3.51M | 1.32% | 0.12% | +0.5% | Q4 2022 | |
| $3.42M | 1.29% | 3.07% | New | Q3 2025 | |
| $3.36M | 1.27% | Not reported | +16.4% | Q1 2024 | |
| $3.29M | 1.24% | 0.00% | +10.4% | Q4 2022 | |
| $3.04M | 1.15% | 0.00% | -1.9% | Q1 2025 | |
| OBONEZOne Bio, Corp. | $2.94M | 1.11% | Not reported | +57.9% | Q1 2025 |
| $2.83M | 1.07% | 0.01% | +3.0% | Q1 2024 | |
| $2.63M | 0.99% | 0.03% | -0.8% | Q1 2025 | |
| $2.54M | 0.96% | 0.00% | +25.3% | Q4 2022 | |
| $2.24M | 0.85% | Not reported | +154.5% | Q2 2025 | |
| $1.91M | 0.72% | 0.06% | -14.5% | Q4 2024 | |
| $1.79M | 0.68% | Not reported | -5.0% | Q4 2022 | |
| $1.77M | 0.67% | 0.00% | +132.1% | Q4 2024 | |
| $1.6M | 0.60% | 0.00% | +171.0% | Q4 2022 | |
| $1.42M | 0.53% | 0.00% | +80.8% | Q2 2025 | |
| $1.38M | 0.52% | 0.00% | -19.4% | Q3 2024 | |
| $1.24M | 0.47% | 0.00% | -46.4% | Q4 2022 | |
| $1.23M | 0.46% | 0.00% | Not reported | Q2 2024 | |
| $1.2M | 0.45% | 0.00% | New | Q3 2025 | |
| $1.15M | 0.44% | 0.00% | +294.2% | Q4 2022 | |
| $1.11M | 0.42% | Not reported | Not reported | Q1 2024 | |
| $1.08M | 0.41% | 0.00% | Not reported | Q1 2025 | |
| $1.05M | 0.40% | Not reported | +8.7% | Q4 2022 | |
| $927K | 0.35% | 0.00% | Not reported | Q3 2024 | |
| $921K | 0.35% | 0.00% | -22.7% | Q3 2024 | |
| $877K | 0.33% | 0.00% | -66.0% | Q4 2023 | |
| $772K | 0.29% | 0.00% | -18.0% | Q2 2025 | |
| $641K | 0.24% | 0.00% | New | Q3 2025 | |
| $546K | 0.21% | 0.00% | -26.5% | Q4 2022 | |
| $526K | 0.20% | 0.00% | -73.8% | Q2 2024 | |
| $518K | 0.20% | 0.00% | New | Q3 2025 | |
| $492K | 0.19% | Not reported | -43.8% | Q1 2024 | |
| $479K | 0.18% | 0.00% | New | Q3 2025 | |
| $436K | 0.16% | 0.00% | +1.1% | Q1 2024 | |
| $428K | 0.16% | 0.00% | -67.0% | Q2 2025 | |
| $395K | 0.15% | Not reported | +19.9% | Q4 2024 | |
| $381K | 0.14% | 500.45% | 0.0% | Q4 2022 | |
| $371K | 0.14% | 0.00% | New | Q3 2025 | |
| $361K | 0.14% | 0.00% | -23.8% | Q2 2025 | |
| $357K | 0.13% | 0.00% | +18.5% | Q4 2022 | |
| $355K | 0.13% | 0.00% | +17.4% | Q4 2022 | |
| $354K | 0.13% | 0.06% | -42.9% | Q4 2024 | |
| $353K | 0.13% | Not reported | New | Q3 2025 | |
| $353K | 0.13% | 0.00% | -18.6% | Q1 2024 | |
| $352K | 0.13% | 0.00% | New | Q3 2025 | |
Premium opens every quarter this fund has filed